CARDIOVASCULAR PHARMACEUTICAL PREPARATIONS

Brand Owner (click to sort) Address Description
CARDIOMEDS Konur, David C. 225 Dunn Street Houma LA 70360 Cardiovascular pharmaceutical preparations;
DOPACARD FISONS PLC FISON HOUSE, PRINCES STREET IPSWICH, SUFFOLK CARDIOVASCULAR PHARMACEUTICAL PREPARATIONS;
DUVAS MARION MERRELL DOW INC. KANSAS CITY MO 641140480 cardiovascular pharmaceutical preparations;
MARIZYME MARIZYME, INC. Ste. 205 555 Heritage Drive Jupiter FL 33458 Cardiovascular pharmaceutical preparations; pharmaceutical preparations for dental health; Pharmaceuticals preparations for medical or veterinary purposes, namely, saline solution for medical use preserving vascular conduits or organs; a preservation solution used for storing harvested vessels that will be used for coronary artery bypass grafts or peripheral vascular procedures, veterinary dental health preparations for plaque reduction; veterinary dental health preparations for disclosing plaque; pharmaceutical preparations for wound care; pharmaceutical preparations for tissue repair; pharmaceutical enzymatic preparations for wound debridement, wound healing, cell isolation and harvesting, biofilm removal from soft and hard tissues; in vitro microfluidic test kits for clinical, professional, medical or consumer use consisting primarily of reagents together with test equipment in the nature of a medical testing device for monitoring conditions and diagnosing disease;Providing wholesale and retail store sales of pharmaceutical products; Providing wholesale and retail store sales of veterinary products; Providing wholesale and retail store sales of medical testing devices;
MILDRONAT GRINDEKS, AS Krustpils Street 53 RIGA LV-1057 Latvia Cardiovascular pharmaceutical preparations; Dietary food supplements; Dietary supplements; Food for babies; Medical dressings; Medical plasters; Pharmaceutical preparations acting on the central nervous system; Sanitary preparations for medical purposes;
MYINFLA FINCHLEY RESEARCH & DEVELOPMENT INC. 6111 Royalmount Avenue, Suite #100 Montreal, Quebec H4P2T4 Canada cardiovascular pharmaceutical preparations;
NATISPRAY LABORATOIRE NATIVELLE (SOCIETE ANONYME) 34, RUE DE LA FEDERATION PARIS France CARDIOVASCULAR PHARMACEUTICAL PREPARATIONS;NATI SPRAY;
NEXAM HOECHST MARION ROUSSEL, INC. 10236 Marion Park Drive Kansas City MO 641371406 cardiovascular pharmaceutical preparations;
PRIFATIN MERRELL PHARMACEUTICALS INC. Sutie 200 3711 Kennett Pike Greenville DE 19807 cardiovascular pharmaceutical preparations;
PROCOR AMERICAN CYANAMID COMPANY Wayne NJ cardiovascular pharmaceutical preparations;
STAY IN CONTROL G. D. SEARLE & CO. Skokie IL cardiovascular pharmaceutical preparations;
TECZEM HOECHST MARION ROUSSEL, INC. 10236 Marion Park Drive Kansas City MO 641371406 cardiovascular pharmaceutical preparations;
TIAMATE MARION MERRELL DOW INC. KANSAS CITY MO 641140480 cardiovascular pharmaceutical preparations;
VALCOR Merrell Dow Pharmaceuticals Inc. Cincinnati OH cardiovascular pharmaceutical preparations;
VERSAPACE UPSHER-SMITH LABORATORIES, INC. 6701 Evenstad Drive Maple Grove MN 55369 Cardiovascular pharmaceutical preparations;VERSATILE PACE;
XETIA MSP Marketing Services (C) Sumneytown Pike P. O. Box 4 West Point PA 19486 Cardiovascular pharmaceutical preparations;
YOU'RE IN CONTROL G. D. SEARLE & CO. Skokie IL cardiovascular pharmaceutical preparations;YOU ARE IN CONTROL;
ZEVAZ MARION MERRELL DOW INC. KANSAS CITY MO 641140480 cardiovascular pharmaceutical preparations;
ZIAC TEVA WOMEN'S HEALTH Building A 400 Interpace Parkway Parsippany NJ 07054 cardiovascular pharmaceutical preparations;
ZIACTIVE AMERICAN CYANAMID COMPANY Wayne NJ cardiovascular pharmaceutical preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.